Michael Bös
Impact in
- Hepatology top 1%
- Hepatitis C virus research
-
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research
Papers in
-
- Neurotransmitter Receptor Influence on Behavior 15
- Hepatology 10
- Hepatitis C virus research 10
- Co-authors
- Andrew J. Sleight (14 shared papers)F. Jenck (7 shared papers)Claus Riemer (4 shared papers)Anne Bourson (5 shared papers)Frank Boess (5 shared papers)Jürgen Wichmann (7 shared papers)James R. Martin (7 shared papers)Jean‐Luc Moreau (5 shared papers)
- Journals
- Journal of Medicinal Chemistry (8 papers)Bioorganic & Medicinal Chemistry Letters (6 papers)Helvetica Chimica Acta (3 papers)British Journal of Pharmacology (2 papers)European Journal of Medicinal Chemistry (2 papers)
- Partner nations
- SwitzerlandCanadaAustria
In The Last Decade
Michael Bös
45 papers receiving 2.8k citations
Michael Bös's Hit Papers
Peers
Comparison fields: 5 of 82
- Hepatology 766
- Cellular and Molecular Neuroscience 769
- Virology 71
- Organic Chemistry 501
- Pharmacology 199
Countries citing papers authored by Michael Bös
This map shows the geographic impact of Michael Bös's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Bös with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Bös more than expected).
Fields of papers citing papers by Michael Bös
This network shows the impact of papers produced by Michael Bös. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Bös. The network helps show where Michael Bös may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Bös, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus Hit paper breakdown → | 2003 | 751 |
| 2 | 1998 | 301 | |
| 3 | 1993 | 234 | |
| 4 | 2003 | 178 | |
| 5 | 1998 | 161 | |
| 6 | 2014 | 152 | |
| 7 | 1996 | 109 | |
| 8 | 2010 | 96 | |
| 9 | 2003 | 91 | |
| 10 | 1997 | 85 | |
| 11 | 2004 | 84 | |
| 12 | 2014 | 83 | |
| 13 | 1998 | 75 | |
| 14 | 2010 | 73 | |
| 15 | 1998 | 69 | |
| 16 | 1998 | 56 | |
| 17 | 2012 | 44 | |
| 18 | 2001 | 40 | |
| 19 | 1998 | 38 | |
| 20 | 1997 | 37 |
About Michael Bös
Michael Bös is a scholar working on Cellular and Molecular Neuroscience, Hepatology, Organic Chemistry, Infectious Diseases and Pharmacology, having authored 46 papers that have together received 3.1k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (15 papers), Hepatitis C virus research (10 papers), Synthesis and biological activity (6 papers), HIV/AIDS drug development and treatment (5 papers), Receptor Mechanisms and Signaling (5 papers), Advanced Synthetic Organic Chemistry (5 papers), Asymmetric Synthesis and Catalysis (4 papers) and Alkaloids: synthesis and pharmacology (3 papers). The work is most often cited by research in Hepatology (766 citations), Cellular and Molecular Neuroscience (769 citations), Virology (71 citations), Organic Chemistry (501 citations) and Pharmacology (199 citations). Michael Bös has collaborated with scholars based in Switzerland, Canada and Austria. Frequent co-authors include Andrew J. Sleight, F. Jenck, Claus Riemer, Anne Bourson, Frank Boess, Jürgen Wichmann, James R. Martin, Jean‐Luc Moreau, Bernard Levet‐Trafit and Joel R. Martin. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Helvetica Chimica Acta, British Journal of Pharmacology and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.